The National Comprehensive Cancer Network (NCCN) took part in the 2024 International Congress of the Asian Oncology Society and the 2024 Chinese Congress on Holistic Integrative Oncology, which highlighted international collaborations to improve cancer therapy and outcomes across China and Asia.
Background
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) help define and advance high-quality, high-value, patient-centered cancer care across the world. There are currently 88 different NCCN Guidelines, featuring recommendations from multidisciplinary expert panels for treating nearly the vast majority of cancer types. The NCCN Guidelines also offer recommendations on screening, prevention, and supportive care. Frequently updated, the NCCN Guidelines were downloaded more than 15 million times in 2023 worldwide, with nearly 1 million downloads from China alone.
Overview of the Event
During the 2024 International Congress of the Asian Oncology Society and the 2024 Chinese Congress on Holistic Integrative Oncology, the NCCN collaborated with leading oncology groups in China, including the Chinese Gynecologic Cancer Society and the Shanghai Yanxin Cultural Firm. Through the ongoing collaboration, the NCCN worked with leading gynecologic experts in China to translate, adapt, and update NCCN Guidelines for Gynecologic Cancers such as cervical cancer, gestational trophoblastic neoplasia, ovarian cancer, uterine neoplasms, and vulvar cancer.
The NCCN has also collaborated with Medlive. This recently reviewed collaboration facilitates the dissemination of NCCN Guidelines in English and Chinese.
Conclusions
“NCCN is honored to participate in this important meeting,” emphasized Wui-Jin Koh, MD, Chief Medical Officer of the NCCN. “China is one of the top three countries in the world in terms of number of registered users for our website and downloads of NCCN Guidelines. We are grateful that our evidence-based expert consensus–driven recommendations are being utilized to guide and improve care for [patients] with cancer throughout China and all of Asia,” he concluded.
Individuals can access the materials by visiting nccn.org.
Disclosure: The two congresses were sponsored by the China Anti-Cancer Association (CACA), Chinese Institute of Development Strategy on Holistic Integrative Medicine, and Asian Oncology Society (AOS).
